Differential lipid binding of truncation mutants of Galleria mellonella apolipophorin III

被引:19
作者
Dettloff, M
Niere, M
Ryan, RO
Luty, R
Kay, CM
Wiesner, A
Weers, PMM
机构
[1] Childrens Hosp, Oakland Res Inst, Lipid Biol Hlth & Dis Res Grp, Oakland, CA 94609 USA
[2] Free Univ Berlin, Inst Biol Zool, D-14195 Berlin, Germany
[3] Univ Alberta, PENCE, Edmonton, AB T6G 2S2, Canada
关键词
D O I
10.1021/bi0200108
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apolipophorin III (apoLp-III) is a prototype exchangeable apolipoprotein that is amenable to structure-function studies. The protein folds as a bundle of five amphipathic a-helices and undergoes a dramatic conformational change upon lipid binding. Recently, we have shown that a truncation mutant of Galleria mellonella apoLp-III comprising helices 1-3 is stable in solution and able to bind to lipid surfaces [Dettloff, M., Weers, P. M. M., Niere, M., Kay, C. M., Ryan, R. O., and Wiesner, A. (2001) Biochemistry 40, 3150-3157]. To investigate the role of the C-terminal helices in apoLp-III structure and function, two additional 3-helix mutants were designed: a core fragment comprising, helix (H) 2-4, and a C-terminal fragment (H3-5). Each truncation mutant retained the ability to associate spontaneously with dimyristoylphosphatidy1choline (DMPC) vesicles, transforming them into discoidal complexes. The rate of apolipoprotein-dependent DMPC vesicle transformation decreased in the order H1-3 > H2-4 > H3-5. Truncation of two helices led to a significant decrease in a-helical content in buffer in each case, from 86% (wild-type) to 50% (H1-3), 28% (H2-4), and 24% alpha-helical content (H3-5). On the other hand, trifluoroethanol or complexation with DMPC induced the truncation mutants to adopt a high a-helical structure similar to that of wild-type protein (84-100% alpha-helical structure). ApoLp-III(H1-3) and apoLp-III(H2-4), but not apoLp-III(H3-5), were able to prevent phospholipase-C-induced low density lipoprotein aggregation, indicating that interaction of the C-terminal fragment with spherical lipoprotein surfaces was impaired. As lipoprotein binding is significantly affected and DMPC transformation rates are relatively slow upon removal of N-terminal helices, the data indicate that structural elements necessary for lipid interaction reside in the N-terminal part of the protein.
引用
收藏
页码:9688 / 9695
页数:8
相关论文
共 45 条
[21]   Insect immune activation by apolipophorin III is correlated with the lipid-binding properties of this protein [J].
Niere, M ;
Dettloff, M ;
Maier, T ;
Ziegler, M ;
Wiesner, A .
BIOCHEMISTRY, 2001, 40 (38) :11502-11508
[22]   Only the two end helixes of eight tandem amphipathic helical domains of human apo A-I have significant lipid affinity - Implications for HDL assembly [J].
Palgunachari, MN ;
Mishra, VK ;
LundKatz, S ;
Phillips, MC ;
Adeyeye, SO ;
Alluri, S ;
Anantharamaiah, GM ;
Segrest, JP .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (02) :328-338
[23]   ESTIMATION OF GLOBULAR PROTEIN SECONDARY STRUCTURE FROM CIRCULAR-DICHROISM [J].
PROVENCHER, SW ;
GLOCKNER, J .
BIOCHEMISTRY, 1981, 20 (01) :33-37
[24]   ALIGNMENT OF THE APOLIPOPHORIN-III ALPHA-HELICES IN COMPLEX WITH DIMYRISTOYLPHOSPHATIDYLCHOLINE - A UNIQUE SPATIAL ORIENTATION [J].
RAUSSENS, V ;
NARAYANASWAMI, V ;
GOORMAGHTIGH, E ;
RYAN, RO ;
RUYSSCHAERT, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (21) :12542-12547
[25]   Lipid transport biochemistry and its role in energy production [J].
Ryan, RO ;
van der Horst, DJ .
ANNUAL REVIEW OF ENTOMOLOGY, 2000, 45 :233-260
[26]  
RYAN RO, 1995, J LIPID RES, V36, P1066
[27]  
SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303
[28]   The lipid binding activity of the exchangeable apolipoprotein apolipophorin-III correlates with the formation of a partially folded conformation [J].
Soulages, JL ;
Bendavid, OJ .
BIOCHEMISTRY, 1998, 37 (28) :10203-10210
[29]   Dynamics and hydration of the α-helices of apolipophorin III [J].
Soulages, JL ;
Arrese, EL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (23) :17501-17509
[30]  
SOULAGES JL, 1994, ADV PROTEIN CHEM, V45, P371